Related Experiment Video
Updated: Jun 29, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell
Hongkun Sun1,2, Juanjuan Shang1, Xiao Liu2
1Department of Hematology, Shandong Provincial Hospital, Shandong University, 250021, Jinan, Shandong, China.
High expression of eukaryotic initiation factor 3a (eIF3a) in diffuse large B-cell lymphoma (DLBCL) correlates with poor prognosis and promotes tumor growth. Targeting eIF3a may offer a new therapeutic strategy for DLBCL patients.
Area of Science:
- Oncology
- Molecular Biology
- Translational Medicine
Background:
- Diffuse large B-cell lymphoma (DLBCL) has a high relapse rate after standard treatment.
- Eukaryotic initiation factor 3a (eIF3a) is implicated in tumorigenesis and therapeutic response.
- Understanding eIF3a's role in DLBCL is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the biological role of eIF3a in DLBCL.
- To evaluate eIF3a as a prognostic biomarker in DLBCL.
- To explore eIF3a as a potential therapeutic target for DLBCL.
Main Methods:
- Utilized RNA-seq datasets from GEO to analyze eIF3a expression and prognosis.
- Assessed eIF3a protein levels via western blot and immunohistochemistry.
- Performed eIF3a knockdown in DLBCL cells to determine its biological functions and analyzed differentially expressed genes (DEGs).
Main Results:
- Elevated eIF3a expression in DLBCL patients correlated with worse prognosis.
- eIF3a knockdown suppressed DLBCL cell proliferation, reduced proliferation-related proteins, and increased apoptosis.
- Identified 114 DEGs linked to cell cycle and tumor immunity; eIF3a and DEG mutations affected chemosensitivity and signaling pathways.
Conclusions:
- First study to demonstrate high eIF3a expression and its prognostic significance in DLBCL.
- eIF3a promotes DLBCL development by regulating cell proliferation and apoptosis.
- eIF3a is linked to immune profiles and chemosensitivity, suggesting its potential as a prognostic biomarker and therapeutic target.
Related Concept Videos
Negative Regulator Molecules
Differentiation of Common Myeloid Progenitor Cells
Abnormal Proliferation
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle

